Articles

Oramed (ORMP) stock is falling hard Thursday after announcing a Phase 3 clinical trial of its diabetes treatment missed its primary endpoint. More

Disney (DIS) stock is a hot topic among traders as the company prepares for a battle with activist investor Trian Partners. More

Lucid Motors won the dismissal of an investor suit and is funded through 2024. The challenge for LCID stock now is Lucid's profitability. More

The ability of small investors to squeeze institutions that short stocks may dissuade some from betting on disaster with BBBY stock. More

These three high-growth stocks provide everything long-term investors want, including an attractive entry point right now. More

With the chances of a U.S. recession looking increasingly remote as the days go on, here are seven consumer discretionary stocks to buy. More

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! More

Subscriber Sign in